Advertisement

Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis: a randomized, double-blind clinical trial

  • Roberto Vanelli
  • Pietro Costa
  • Stefano Marco Paolo RossiEmail author
  • Francesco Benazzo
Knee

Abstract

This randomized, double-blind clinical trial was conducted over 16 weeks to assess the efficacy and safety profile of intra-articular polynucleotides gel injections in the treatment of knee osteoarthritis associated with persistent knee pain. 60 patients were enrolled and randomized to receive intra-articular polynucleotides (n = 30) or hyaluronan (n = 30); patients received five weekly intra-articular knee injections and the follow-up period was 3 months after the end of treatment. Primary endpoint was to determine polynucleotides (PN) efficacy in reducing knee pain at the end of the study, over baseline value and over standard hyaluronan viscosupplementation (HA). Pain levels were measured using a 0–10 cm Visual Analogue Scale (VAS). Secondary endpoints included Knee Osteoarthritis Outcome Score (KOOS), NSAIDs consumption, crackling during movement and articular mobility limitation. The mean global VAS pain decreased from 5.7 ± 1.9 cm (T0) to 1.9 ± 1.5 cm (T16) in polynucleotide group and from 4.9 ± 2.0 cm (T0) to 2.1 ± 1.4 cm (T16) in hyaluronan group. The reduction in pain was statistically significant for both groups. KOOS increases from baseline values were statistically significant in both groups. No significant adverse events were reported. These findings suggest that intra-articular polynucleotides can be a valid alternative to traditional hyaluronan supplementation for the treatment of knee osteoarthritis.

Keywords

Polynucleotides Condrotide Turnover Joint Osteoarthritis Hyaluronic acid Intra-articular 

Notes

Acknowledgments

The study took place at the IRCCS Foundation, Orthopaedic and Traumatology Department, S. Matteo Hospital Institute, University of Pavia, Italy. This work was supported by Mastelli s.r.l., Sanremo Italy. Special thanks to Dr. Giulia Cattarini and Dr. Andrea Armando for their assistance with the study and manuscript. Authors would also like to thank Prof. Martino Recchia for the statistical analysis.

References

  1. 1.
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049CrossRefPubMedGoogle Scholar
  2. 2.
    Altman RD, Aven A, Holmburg CE et al (1994) Capsaicin cream 0.025% as monotherapy for osteoarthritis: a double-blind study. Semin Arthritis Rheum 23:25–33CrossRefGoogle Scholar
  3. 3.
    Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. Can Med Assoc J 172:1039–1043CrossRefGoogle Scholar
  4. 4.
    Bellamy N, Campbell J, Robinson V et al (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321Google Scholar
  5. 5.
    De Aloe G, Rubegni P, Biagioli M, Taddeucci P, Fimiani M (2004) Skin graft donor site and use of PDRN as a treatment for skin regeneration: a randomized, controlled, double-blind, clinical trial. Wounds 16:258–263Google Scholar
  6. 6.
    Guizzardi S, Galli C, Govoni P, Boratto P, Cattarini G, Martini D, Belletti S, Scandroglio R (2003) Polydeoxyribonucleotide (PDRN) promotes human osteoblast proliferation: a new proposal for bone tissue repair. Life Sci 73:1973–1983CrossRefPubMedGoogle Scholar
  7. 7.
    Karlsson J, Sjögren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41:1240–1248CrossRefPubMedGoogle Scholar
  8. 8.
    Knutsen G et al (2007) A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89:2105–2112CrossRefPubMedGoogle Scholar
  9. 9.
    Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis—a meta-analysis. JAMA 23:3115–3121CrossRefGoogle Scholar
  10. 10.
    Muratore O, Cattarini G, Gianoglio S, Tonoli EL, Saccà SC, Ghiglione D, Venzano D, Ciurlo C, Lantieri PB, Schito GC (2003) A human placental polydeoxyribonucleotide (PDRN) may promote the growth of human corneal fibroblasts and iris pigment epithelial cells in primary cultures. New Microbiol 26:13–26PubMedGoogle Scholar
  11. 11.
    Muratore O, Pesce Schito A, Cattarini G, Tonoli EL, Gianoglio S, Schiappacasse S, Felli L, Picchetta F, Schito GC (1997) Evaluation of the trophic effect of human placental PDRN on human knee skin fibroblasts in primary cultures. Cell Mol Life Sci 53:279–285CrossRefPubMedGoogle Scholar
  12. 12.
    Murray CJ, Lopez AD (1996) Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 274:740–743CrossRefPubMedGoogle Scholar
  13. 13.
    Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A (2009) Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8:110–123CrossRefPubMedGoogle Scholar
  14. 14.
    Reichenbach S, Sterchi R, Scherer M et al (2007) Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 146:580–590PubMedGoogle Scholar
  15. 15.
    Roos EM, Lohmander LS (2003) The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to Osteoarthritis. Health Qual Life Outcomes 1:64CrossRefPubMedGoogle Scholar
  16. 16.
    Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD (1998) Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ther 28:88–96PubMedGoogle Scholar
  17. 17.
    Roos E, Toksvig-Larsen S (2003) Knee injury and Osteoarthritis Outcome Score (KOOS)—validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 1:17CrossRefPubMedGoogle Scholar
  18. 18.
    Sini P, Denti A, Cattarini G, Daglio M, Tira ME, Balduini C (1999) Effect of polydeoxyribonucleotides on human fibroblasts in primary cultures. Cell Biochem Funct 17:107–114CrossRefPubMedGoogle Scholar
  19. 19.
    Thellung S, Florio T, Maragliano A, Cattarini G, Schettini G (1999) Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvment of A2 purinergic receptors subtypes. Life Sci 64:1661–1674CrossRefPubMedGoogle Scholar
  20. 20.
    Valdatta L, Thione A, Mortarino C, Buoro M, Tuinder S (2004) Evaluation of the efficacy of polydeoxyribonucleotide in the healing process of autologous skin graft donor sites: a pilot study. Curr Med Res Opin 20:403–408CrossRefPubMedGoogle Scholar
  21. 21.
    Van Assche D, Staes F, Van Caspel D, Vanlauwe J, Bellemans J, Saris DB, Luyten FP (2009) Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol ArthroscGoogle Scholar
  22. 22.
    Woessner JF, Howell DS (1993) Joint cartilage degradation: basic and clinical aspects. Marcel Dekker, New YorkGoogle Scholar
  23. 23.
    Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Roberto Vanelli
    • 1
  • Pietro Costa
    • 1
  • Stefano Marco Paolo Rossi
    • 1
    Email author
  • Francesco Benazzo
    • 1
  1. 1.IRCCS Foundation, Orthopaedic and Traumatology Department, S. Matteo Hospital InstituteUniversity of PaviaPaviaItaly

Personalised recommendations